Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Kamada Ltd.’s names, not what it holds today.
Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
13
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'07'08'09'11'12'18'20'21'23
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
Biotechnology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
KAMADA LTD. its own name
IL, as the owner printed on each patent
9 publishedKAMADA LTD. its own name
named as the applicant on its applications, in IL. 1 more under the same name are not counted (printed in IN)
4 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 14, 2023 | 11,814,442 | Immunoglobulin compositions and process for obtaining the same | Biotechnology | KAMADA LTD. |
| Mar 30, 2021 | 10,960,062 | Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases | Pharmaceuticals | KAMADA LTD. |
| Jul 28, 2020 | 10,722,535 | Compositions derived from Cohn fraction paste and use thereof | Pharmaceuticals | KAMADA LTD. |
| Jun 23, 2020 | 10,689,435 | Therapy and prophylaxis of infectious disease caused by zika virus | Pharmaceuticals | KAMADA LTD. |
| Jul 5, 2011 | 7,973,005 | Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases | Pharmaceuticals | KAMADA LTD. |
| Feb 1, 2011 | 7,879,800 | Large scale preparation of alpha-1 proteinase inhibitor and use thereof | Pharmaceuticals | KAMADA LTD. |
| Oct 23, 2007 | 7,285,646 | Ultrapure transferrin for pharmaceutical compositions | Pharmaceuticals | KAMADA LTD. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 25, 2021 | 2021/0085765 | METHODS AND COMPOSITIONS FOR PRE-EMPTIVE TREATMENT OF GRAFT VERSUS HOST DISEASE | Pharmaceuticals | KAMADA LTD. |
| Mar 25, 2021 | 2021/0085764 | DRY POWDER FORMULATIONS OF ALPHA-1 ANTITRYPSIN | Pharmaceuticals | KAMADA LTD. |
| Jan 14, 2021 | 2021/0008183 | METHODS OF INDUCING IMMUNE TOLERANCE AND REDUCING ANTI-DRUG ANTIBODY RESPONSE | Pharmaceuticals | KAMADA LTD. |
| Oct 22, 2020 | 2020/0330565 | METHODS AND COMPOSITIONS FOR PRE-EMPTIVE TREATMENT OF GRAFT VERSUS HOST DISEASE | Pharmaceuticals | KAMADA LTD. |
| Sep 10, 2020 | 2020/0282031 | METHODS AND COMPOSITIONS FOR REDUCING LUNG INJURY ASSOCIATED WITH LUNG TRANSPLANTATION | Pharmaceuticals | KAMADA LTD. |
| May 21, 2020 | 2020/0157242 | IMMUNOGLOBULIN COMPOSITIONS AND PROCESS FOR OBTAINING THE SAME | Biotechnology | KAMADA LTD. · patent 11,814,442 granted from it |
| Feb 13, 2020 | 2020/0046815 | MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING DIABETES | Pharmaceuticals | KAMADA LTD. |
| Jan 9, 2020 | 2020/0009234 | METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN PULMONARY DISEASES | Pharmaceuticals | KAMADA LTD. · patent 10,960,062 granted from it |
| Dec 13, 2018 | 2018/0353543 | COMPOSITIONS DERIVED FROM COHN FRACTION PASTE AND USE THEREOF | Pharmaceuticals | KAMADA LTD. · patent 10,722,535 granted from it |
| Aug 23, 2012 | 2012/0211005 | PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR | Pharmaceuticals | KAMADA LTD. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.